TwinStrand Biosciences Funding: $78M Raised, Series B (2021)
TwinStrand Biosciences is based in Seattle. It has raised $78M in total funding. Latest round: Series B.
TwinStrand Biosciences funding overview
TwinStrand Biosciences is based in Seattle. TwinStrand Biosciences has raised $78M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2021. The round record for TwinStrand Biosciences runs through 2021; nothing later has been disclosed. Investors on record include Section 32, Madrona Venture Group, Soleus Capital, Janus Henderson Investors, Ridgeback Capital, Alexandria Venture Investments. 6 distinct backers are named across the disclosed rounds.
Frequently asked about TwinStrand Biosciences funding
How much has TwinStrand Biosciences raised?
TwinStrand Biosciences has raised $78M in total disclosed funding across the rounds on record.
Who has invested in TwinStrand Biosciences?
Section 32, Madrona Venture Group, Soleus Capital, Janus Henderson Investors, Ridgeback Capital, Alexandria Venture Investments are named among the investors backing TwinStrand Biosciences.
What was the latest TwinStrand Biosciences funding round?
The most recent disclosed round is a Series B, announced in May 2021.
Where is TwinStrand Biosciences based?
TwinStrand Biosciences is based in Seattle.
When did TwinStrand Biosciences last raise?
The last disclosed TwinStrand Biosciences round closed in May 2021 at Series B.
Every TwinStrand Biosciences figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Seattle at a similar stage.
